Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|November 19, 2021
[From treating in the dark towards eliminating hepatitis C]Peer Brehm Christensen, Jacob Søholm, Anne Øvrehus
Infectious Diseases (London, England)|February 13, 2025
Ability to return to work and persistent symptoms six months after viral meningitis - a retrospective single-centre cohort studyAlbulena Imishti, Mathilde Jepsen Nissen, Anne Øvrehus, et al.
BMJ Open|November 10, 2020
The Copenhagen test and treat hepatitis C in a mobile clinic study: a protocol for an intervention study to enhance the HCV cascade of care for people who inject drugs (T'N'T HepC)Jeffrey Victor Lazarus, Anne Øvrehus, Jonas Demant, et al.
Addiction (Abingdon, England)|October 23, 2018
Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort studyAnne Øvrehus, Stine Nielsen, Janne Fuglsang Hansen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 25, 2023
Hepatitis C time trends in reported cases and estimates of the hidden population born before 1965, Denmark and Sweden, 1990 to 2020Peer Brehm Christensen, Birgit Debrabant, Susan Cowan, et al.
Open Forum Infectious Diseases|January 26, 2018
Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk FactorsJanne Fuglsang Hansen, Sofie Hallager, Anne Øvrehus, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2021
Inferior cure rate in pilot study of 4-week glecaprevir/pibrentasvir treatment with or without ribavirin of chronic hepatitis CLone W Madsen, Peer B Christensen, Ulrik Fahnøe, et al.
Microbiology Resource Announcements|October 14, 2021
Characterization of a Novel Hepatitis C Virus Genotype 1 Subtype from a Patient Failing 4 Weeks of Glecaprevir-Pibrentasvir TreatmentMartin S Pedersen, Ulrik Fahnøe, Lone W Madsen, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2023
Use of molnupiravir: A Danish nationwide drug utilization studyLouise Ladebo, Lotte Rasmussen, Peter Bjødstrup Jensen, et al.
The International Journal on Drug Policy|September 29, 2023
Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, DenmarkJonas Demant, Louise Krohn-Dehli, Jannet Van der Veen, et al.
Pageof 3